Industry Insights

  1. Streamlining Recombinant Protein Production

    Bringing a recombinant protein to market requires a substantial investment of time and resources, and the process is generally complex and subject to technical pitfalls.

  2. 6 Types Of Diseases Related To Endotoxins Of Gram-Negative Bacteria

    Almost any environment is appropriate for the development of Gram-negative bacteria, given that contamination with these bacteria is very common.

  3. Impact Of Incorrect Forecasts On New Drug Product Launches

    Pharmaceutical company marketing executives have become more accurate in positioning their new product in the marketplace, profiling prescribers, and understanding and responding to the reimbursement landscape. What is still a quagmire for pharma companies is predicting the actual demand for products and the timing of that demand.

  4. Changes To The Opioid Labeling Regulation

    FDA is revising warnings and safety information for immediate-release (IR) opioid labeling. The goal is to inform doctors better about the risks of opioids and how to prescribe these drugs safely.

  5. Incorporate Data Integrity Into Your Pharma Quality Management System

    A viable QMS cannot be based upon anything except data and records that are attributable, legible, contemporaneous, original, accurate, complete and easily retrievable. 

  6. Tackling The Challenge Of Scalability

    Commercial production of biologics requires development of a fermentation process that is time- and cost-efficient, and highly reliable. In an early stage of development, many process parameters are evaluated at small or bench scale to find the optimal conditions.

  7. Tips For Preparing And Using Buffers With Your Chromatography System

    One of the important and often overlooked tips to increase the performance of a chromatography system is to understand how to best use and prepare buffers and solvents.

  8. Simulation Software Enhances Packaging Line Design

    This article explains how affordable and user-friendly simulation software is being used to design energy-efficient and cost-effective packaging processes.

  9. The Key To Unlocking Foreign Pharmaceutical Markets

    The opportunities in developing global markets appear limitless, but the obstacles surrounding them can be daunting. With issues ranging from language barriers to protecting intellectual property rights, each solution must be as unique as the country the work is developed in. Download this eBook to learn key strategies to unlock foreign pharma markets.

  10. Phase II And Phase III Studies Standard Protocol A Template For Success?

    The ultimate goal of a template is to help investigators create high quality protocols that are consistent, well organized and contain all pertinent information needed to be properly reviewed.